Bioxytran Announces Broad Spectrum Antiviral Activity
BOSTON, MASSACHUSETTS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral...
Stay updated with breaking news from Michael Sheikh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON, MASSACHUSETTS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral...
First Antiviral Drug in GlycovirologyBOSTON, MASSACHUSETTS, Aug. 24, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinica...
BOSTON, MASSACHUSETTS, Aug. 08, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the "Company"), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral diseases, announced the
IN8bio, Inc (NASDAQ: INAB) just released very enticing positive data from their phase 1 investigator-sponsored trial of INB-100 in Leukemia patients.
On Friday, Petros Pharmaceuticals (NASDAQ: PTPI) stock witnessed a significant uptick in value, despite the absence of any company updates regarding its men's health pharmaceutical products. There’s no evidence of any press release or filed reports with the U.S. Securities or Exchange Commission to explain the rise in value. To Find out the inside Scoop